Search

195 Result(s)

Science Focus

Oncology and Cancer Immunology

Science Stories

SIRPα: A New Chapter in Cancer Immunology Research

Boehringer Ingelheim scientists are exploring a research path scientifically less travelled by investigating a new target in the innate immune system

Science Stories

Taking KRAS Cancer On

Hear from Darryl McConnell, Research Site Head, Vienna, as he describes how we aim to drug all forms of KRAS

Empowering Patients

Taking Cancer on Through Flavour

Simple, nutritious recipes for people with cancer

Science Stories

What does it mean to drug cancer’s “big four”?

Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums.

Science Stories

Protein Degraders: Changing the Game in Cancer Drug Discovery

Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach

Lung Cancer

Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all lung cancer cases. Find out more about testing and treatment here.

Cancer

Taking Cancer On: The Podcast

From early stage discovery to clinical trials and approval, we’re Taking Cancer On. Click here to access the podcast homepage, where you will find all the available episodes.

Across Cancer Types

Cancer’s Big 4, our focus on KRAS

Drugging the undruggable

Article

Taking Cancer on at Diagnosis

Video capturing patient, partner and HCP advice for people starting their own cancer journeys.

Article

High Protein Diets for Cancer Patients

A high protein diet may be advisable when undertaking cancer treatment. Click here to learn more from Dr. Clare Shaw.

Article

Weight Loss from Cancer Treatment

Dr. Clare Shaw offers her advice for patients who have lost weight during cancer treatment and would like to put it back on. Click here to learn more.

Empowering Patients

Taking Cancer on Together

Find out how our colleagues are empowering patients to Take Cancer On through their work.

Science Stories

Our Four Pillars of Cancer Immunology Research

We have developed a robust pipeline of clinical assets including immuno-oncology investigational therapies, find out more about them here.

Article

Dietary Advice for Specific Cancers

Hear Dr. Clare Shaw’s recommendations for seeking specific cancer nutrition advice

Cancer

Win Fight Against Cancer

At Boehringer Ingelheim, we believe this can be the generation that redefines many cancers as curable diseases. We want to be part of this transformation.

Photo of scientist Birgit Wilding in the laboratory

Science Stories

Targeting HER2 in cancer: The story of zongertinib

Our cancer researchers share insights into the discovery of zongertinib, our investigational HER2 tyrosine kinase inhibitor.

Illustration of a patient receiving help for a healthcare professional

Cancer

The power of patient advocacy in cancer care

Learn more about patient Larry and UICC president Jeff Dunn's commitment to patient empowerment.

Group of scientists from the Chemical Development department at Boehringer Ingelheim gathering in the kilolab facilities, where the first kilogram quantities of the drug substance is manufactured

Science Stories

Targeting MDM2-p53 in cancer: The story of brigimadlin

Our perseverance and passion for science led to the discovery of brigimadlin, our MDM2-p53 antagonist. It is being clinically investigated as a potential treatment for dedifferentiated liposarcoma, a rare cancer with significant unmet needs.

Lamine Mbow, Global Head of Cancer Immunology and Immune Modulation at Boehringer Ingelheim, shares our approach to Immuno-oncology

Science Stories

T-cell engagers: Reawakening T-cells to fight cancer

Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology, highlighting our T-cell engagers platform and how we are driving innovation to deliver meaningful advances to people with cancer.